Pieris Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

Related-Party Transactions (Tables)

12 Months Ended

9 Months Ended

Dec. 31, 2013

Sep. 30, 2014

Pieris AG has incurred the following expenses related to TUM (excluding value added taxes):


	Years ended December 31,
	2013		2012
Transfer of licenses and protective rights	$	66,390	$	19,290
Research		22,573		131,172

Total expenses incurred with TUM	$	88,963	$	150,462

Pieris AG has incurred the following expenses related to TUM (excluding value added taxes):


	Nine months ended September 30,
	2014		2013
Transfer of licenses and protective rights	$	50,839	$	49,405
Research		—		22,454

Total expenses incurred with TUM	$	50,839	$	71,859